BioLife Solutions, Inc. Repayments of Secured Debt
BioLife Solutions, Inc. (BLFS) reported Repayments of Secured Debt of $5.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSecuredDebt · last filed 2026-08-06
- BioLife Solutions, Inc. repayments of secured debt for the quarter ending 2026-06-30 was $2.50M, a 0.00% change year-over-year.
- BioLife Solutions, Inc. repayments of secured debt for the quarter ending 2026-03-31 was $2.50M, a 0.00% change year-over-year.
- BioLife Solutions, Inc. repayments of secured debt for the quarter ending 2025-12-31 was $2.50M, a 0.00% change year-over-year.
- BioLife Solutions, Inc. repayments of secured debt for the quarter ending 2025-09-30 was $2.50M, a 0.00% change year-over-year.
- BioLife Solutions, Inc. repayments of secured debt for fiscal 2025 was $10.00M, a 100.00% increase from fiscal 2024.
- BioLife Solutions, Inc. repayments of secured debt for fiscal 2024 was $5.00M, a 1566.67% increase from fiscal 2023.
- BioLife Solutions, Inc. repayments of secured debt for fiscal 2023 was $300.00K, a 81.99% decline from fiscal 2022.
- BioLife Solutions, Inc. repayments of secured debt for fiscal 2022 was $1.67M.
| Period end | Repayments of Secured Debt 3 month | Repayments of Secured Debt 6 month | Repayments of Secured Debt 9 month | Repayments of Secured Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.00M 10-Q · filed 2026-08-06 | $7.50M derived: sum of 3 quarters · filed 2026-08-06 | $10.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.50M 10-Q · filed 2026-05-07 | $5.00M derived: sum of 2 quarters · filed 2026-05-07 | $7.50M derived: sum of 3 quarters · filed 2026-05-07 | $10.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.00M derived: sum of 2 quarters · filed 2026-02-26 | $7.50M derived: sum of 3 quarters · filed 2026-08-06 | $10.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.00M derived: sum of 2 quarters · filed 2026-08-06 | $7.50M 10-Q · filed 2025-11-06 | $10.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.00M 10-Q · filed 2026-08-06 | $7.50M derived: sum of 3 quarters · filed 2026-08-06 | $10.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.50M 10-Q · filed 2026-05-07 | $5.00M derived: sum of 2 quarters · filed 2026-05-07 | $7.50M derived: sum of 3 quarters · filed 2026-05-07 | $7.50M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.00M derived: sum of 2 quarters · filed 2026-02-26 | $5.00M derived: sum of 3 quarters · filed 2026-02-26 | $5.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.50M derived: sum of 2 quarters · filed 2025-11-06 | $2.50M 10-Q · filed 2025-11-06 | $2.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $300.00K 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $300.00K 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.67M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $1.75M 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |